NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



New breast cancer research from S. Carkaci et al outlined



April 9th, 2009

According to recent research from the United States, "Our objective was to retrospectively evaluate F-18-FDG PET/CT in the initial staging of inflammatory breast cancer (IBC). The institutional review board waived informed consent and approved this study, which was compliant with the Health insurance Portability and Accountability Act."

"The cases of 1 women with a mean age of 50 y (range, 25-71 y) and newly diagnosed IBC who underwent F-18-FDG PET/CT at diagnosis were retrospectively reviewed. All PET/CT images were analyzed visually and semiquantitatively by 2 physicians. The maximum standardized uptake value in the primary breast, regional nodes (axillary,...


Source: Women's Health Weekly (2009-04-09)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login